ClinicalTrials.Veeva

Menu

Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata

Mount Sinai Health System logo

Mount Sinai Health System

Status

Terminated

Conditions

Balding
Alopecia
Alopecia Areata

Treatments

Procedure: Hypodermic needle irritation
Procedure: Hair transplantation

Study type

Interventional

Funder types

Other

Identifiers

NCT01385839
GCO 08-0533

Details and patient eligibility

About

The purpose of this study is to look at the safety, as well as the efficacy of hair transplantation compared with irritation with hypodermic needles in the treatment of subjects with refractory alopecia areata.

With this study, the investigators hope to demonstrate that trauma is just as effective as hair transplant in the treatment of recalcitrant alopecia areata of the scalp.

Full description

Alopecia areata is a recurrent, non-scarring type of hair loss that can affect any hair-bearing area. This disorder can present in many different manners. Though medically benign, alopecia areata can result in severe emotional and psychosocial stress in affected individuals. This disease can be treated by hair transplantation.

Hair transplantation is a procedure in which donor hair follicles are harvested from a section of a patient's scalp, and transplanted in another bald recipient area, at which time it will take root and continue to grow. Hairs generally continue to grow indefinitely

During this study, subjects with alopecia areata will have one area (or ½ of a large area) treated by hair transplant and another (or the other ½) treated by simple irritation with a large gauge sterile hypodermic needle.

Enrollment

4 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Subject must have recalcitrant, quiescent, alopecia areata, non-responsive to treatment, for at least 6 months.
  2. Subject must have one patch of alopecia areata greater than 5 cm diameter, of two patches of alopecia areata, each greater than 2.5 cm diameter.

Exclusion criteria

  1. Subjects with active, progressive, alopecia areata.
  2. Subjects who are actively experiencing significant spontaneous regrowth of terminal hair.
  3. Subjects with autoimmune deficiency.
  4. Subjects with a medical condition contraindicating use of anesthesia.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

4 participants in 1 patient group

alopecia areata
Experimental group
Description:
pts will have one area (or ½ of a large area) treated by hair transplant and another (or the other ½) treated by simple irritation with a large gauge sterile hypodermic needle
Treatment:
Procedure: Hypodermic needle irritation
Procedure: Hair transplantation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems